Eisen-Suppressed-Inventions-and-other-Discoveries-True-Stories-of ...

The Suppression of Alternative Medical Therapies 175
Gerson's techniques. Dr. Gerson's therapy has now been practised for
over 60 years, and patients of La Gloria Hospital experience an average
improvement rate of 80 percent in early to moderate cancer and even more
amazingly a 40-50 percent rate of improvement in people with so-called
"terminal" cancer. Other benefits of the Gerson therapy for cancer sufferers
included a marked reduction in pain, and also control of the acute
infections which often led to the death of cancer patients. (The clinic does
however, have a general rule of not accepting people who have previously
undergone chemotherapy, since due to the damage that chemotherapeutic
drugs inflict upon the liver and other organs of the body, sustained
improvement in the condition of these cancer patients is much less likely.
The medical director has also stated that people with tumours which have
spread into the brain and begun to damage the delicate regulatory mechanisms
within it are also less likely than most patients to respond to the
Gerson treatment.)
In 1995, the Gerson Research Association and the Cancer Prevention
and Control Program of the University of California published the results
of a fifteen-year retrospective study which evaluated the success of Gerson
therapy in treating malignant melanoma.
The results of this study showed that people with melanoma who used
Gerson therapy survived longer than people using conventional therapy.
One most encouraging finding was that 100 percent of 14 people with
stage I and II (localized melanoma) survived for five years, compared to
79 percent of 15,798 people who did not follow the Gerson program.
For people with melanoma classified as IIIA and IIIB (regionally metastasized),
70 percent of 33 Gerson patients lived for five years, compared
to 41 percent of 134 melanoma patients under the care of the Fachklinik
Hornheide.
Of those patients with melanoma which had metastasized to distant
lymph nodes, skin areas or subcutaneous tissue—39 percent of 18 Gerson
patients were alive after five years. By comparison, just 6 percent of 194
patients under the care of the Eastern Cooperative Oncology Group survived
five years.
Despite these impressive results of Dr. Gerson's therapies, mainstream
medicine is even less receptive to his ideas and treatment plans now than
when he began publishing the results of his work in the United States in
the 1940s.
In January 1945, the then manager-director of the American Cancer
Society Mr. C. C. Little wrote (to a doctor):
It seems to me that since Dr. Gerson has frankly stated in detail what
his diet is and in addition has given the theory on which he personally